23 related articles for article (PubMed ID: 16944980)
1. Prognostic role of CD82/KAI1 in multiple human malignant neoplasms: a meta-analysis of 31 studies.
Zhu J; Miao C; Liu S; Tian Y; Zhang C; Liang C; Xu A; Cao Q; Wang Z
Onco Targets Ther; 2017; 10():5805-5816. PubMed ID: 29263677
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
[TBL] [Abstract][Full Text] [Related]
3. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
4. CD9 expression is not a prognostic factor in human osteosarcoma.
Kubista B; Erovic BM; Klinger H; Sulzbacher I; Trieb K
Cancer Lett; 2004 Jun; 209(1):105-10. PubMed ID: 15145525
[TBL] [Abstract][Full Text] [Related]
5. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
[TBL] [Abstract][Full Text] [Related]
7. A preliminary investigation of Beta-hCG expression in patients with osteosarcoma.
Masrouha KZ; Khattab R; Tawil A; Abdallah A; Saghieh S; Haidar R; Abboud M; Khoury NJ
J Bone Joint Surg Br; 2012 Mar; 94(3):419-24. PubMed ID: 22371553
[TBL] [Abstract][Full Text] [Related]
8. Bone Microenvironment and Osteosarcoma Metastasis.
Yang C; Tian Y; Zhao F; Chen Z; Su P; Li Y; Qian A
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977425
[TBL] [Abstract][Full Text] [Related]
9. Proteins expressed in osteosarcoma and serum levels as prognostic factors.
Trieb K; Kotz R
Int J Biochem Cell Biol; 2001 Jan; 33(1):11-7. PubMed ID: 11167128
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells in the osteosarcoma microenvironment: their biological properties, influence on tumor growth, and therapeutic implications.
Zheng Y; Wang G; Chen R; Hua Y; Cai Z
Stem Cell Res Ther; 2018 Jan; 9(1):22. PubMed ID: 29386041
[TBL] [Abstract][Full Text] [Related]
11. KAI-1 expression in pediatric high-grade osteosarcoma.
Leavey PJ; Timmons C; Frawley W; Lombardi D; Ashfaq R
Pediatr Dev Pathol; 2006; 9(3):219-24. PubMed ID: 16944980
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
